Firefly luciferase-based chronological measurement of effector CD8+ T-cell activity using a multi-chamber luminometer

被引:1
作者
Hayashi, Ryota [1 ]
Nakatani, Hayato [2 ]
Kawahata, Hinami [2 ]
Fujie, Ryonosuke [1 ]
Kurowarabe, Kaoru [1 ]
Hayasaka, Haruko [1 ,2 ,3 ]
机构
[1] 1Kindai Univ, Grad Sch Sci & Engn, Dept Sci, Higashiosaka, Osaka 5778502, Japan
[2] 2Kindai Univ, Fac Sci & Engn, Higashiosaka, Osaka 5778502, Japan
[3] Kindai Univ, Inst Sci & Technol 3Research, Higashiosaka, Osaka 5778502, Japan
关键词
bioluminescence; CD8(+) T cell; luciferase; melanoma; IMMUNITY; IDENTIFICATION; IMMUNOTHERAPY; CYTOTOXICITY; VACCINE; ASSAY;
D O I
10.4155/bio-2022-0208
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Although cell-mediated cytotoxicity has been evaluated with various protocols, methods for monitoring cytotoxicity in a time series have not been established. This work describes a method for evaluating cytotoxicity using a multi-chamber real-time luminometer. Materials & methods: The efficiency of effector CD8(+) T-cell expansion from melanoma-bearing splenocytes was analyzed. The effect of CD8(+) T cells on the viability of luciferase-expressing target cells was measured by bioluminescence. Results: Melanoma-specific effector CD8(+) T cells were differentiated by in vitro coculture. The melanoma cell growth was significantly inhibited in the presence of in vitro-expanded T cells in the bioluminescence-based time-lapse analysis. Conclusion: The bioluminescence-based assay is a useful method for monitoring the time course of cell viability of target tumor cells.
引用
收藏
页码:1413 / 1421
页数:9
相关论文
共 24 条
[1]   MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100 IS RECOGNIZED BY MELANOMA-DERIVED TUMOR-INFILTRATING LYMPHOCYTES [J].
BAKKER, ABH ;
SCHREURS, MWJ ;
DEBOER, AJ ;
KAWAKAMI, Y ;
ROSENBERG, SA ;
ADEMA, GJ ;
FIGDOR, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :1005-1009
[2]   Oncology Meets Immunology: The Cancer-Immunity Cycle [J].
Chen, Daniel S. ;
Mellman, Ira .
IMMUNITY, 2013, 39 (01) :1-10
[3]  
Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084
[4]   The flow cytometric PKH-26 assay for the determination of T-cell mediated cytotoxic activity [J].
Fischer, K ;
Mackensen, A .
METHODS, 2003, 31 (02) :135-142
[5]   A NOVEL NONRADIOACTIVE CELLULAR CYTOTOXICITY TEST BASED ON THE DIFFERENTIAL-ASSESSMENT OF LIVING AND KILLED TARGET AND EFFECTOR-CELLS [J].
FLIEGER, D ;
GRUBER, R ;
SCHLIMOK, G ;
REITER, C ;
PANTEL, K ;
RIETHMULLER, G .
JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 180 (01) :1-13
[6]   A Simple and Sensitive Method for Measuring Tumor-Specific T Cell Cytotoxicity [J].
Fu, Xinping ;
Tao, Lihua ;
Rivera, Armando ;
Williamson, Shana ;
Song, Xiao-Tong ;
Ahmed, Nabil ;
Zhang, Xiaoliu .
PLOS ONE, 2010, 5 (07)
[7]   Ca2+-induced changes in energy metabolism and viability of melanoma cells [J].
Glass-Marmor, L ;
Penso, J ;
Beitner, R .
BRITISH JOURNAL OF CANCER, 1999, 81 (02) :219-224
[8]  
Luker GD, 2011, METHODS MOL BIOL, V680, P29, DOI 10.1007/978-1-60761-901-7_2
[9]   Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy [J].
Merritt, RE ;
Yamada, RE ;
Crystal, RG ;
Korst, RJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (02) :355-364
[10]   Combinatorial Immunotherapy of Polyinosinic-Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD8 T-cell Responses against Established Tumors [J].
Nagato, Toshihiro ;
Lee, Young-Ran ;
Harabuchi, Yasuaki ;
Celis, Esteban .
CLINICAL CANCER RESEARCH, 2014, 20 (05) :1223-1234